Clinical Trials Logo

Affective Disorders, Psychotic clinical trials

View clinical trials related to Affective Disorders, Psychotic.

Filter by:

NCT ID: NCT00422214 Completed - Depression, Bipolar Clinical Trials

Phase III/Seroquel SR Bipolar Depression Monotherapy - US

Start date: December 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the safety and efficacy of sustained-release quetiapine fumarate (Seroquel®) in the treatment of patients with Acute Bipolar Depression for 8 weeks. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

NCT ID: NCT00422123 Completed - Mania Clinical Trials

Phase 3 /Seroquel SR Acute Mania Monotherapy - US

Start date: January 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the safety and efficacy of sustained-release quetiapine fumarate (Seroquel®) in the treatment of patients with Acute Bipolar Mania for 3 weeks. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

NCT ID: NCT00309686 Completed - Bipolar Disorder Clinical Trials

A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder

Start date: April 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and safety over a 6-week period of paliperidone ER compared with placebo in treating subjects with Bipolar I Disorder who are experiencing a manic or mixed episode while they are taking lithium or valproate. This study will also evaluate the effect of paliperidone ER compared with placebo on overall functioning, on how quickly a response is seen, on improvement in severity of illness, on health-related functional status, on depressive symptoms, and on psychotic symptoms. The relationship between blood levels and the effectiveness and safety of paliperidone ER will be evaluated, including the effect of food relative to time of taking the drug.

NCT ID: NCT00240721 Completed - Mood Disorders Clinical Trials

A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder

Start date: October 2000
Phase: Phase 3
Study type: Interventional

The primary purpose of this study is to evaluate the effectiveness and safety of topiramate compared with placebo in the treatment of acute manic or mixed episodes in patients with Bipolar I Disorder.

NCT ID: NCT00199940 Completed - Schizophrenia Clinical Trials

Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness

Start date: December 2003
Phase: Phase 4
Study type: Interventional

The purpose of this research is to determine if Ziprasidone is safe and effective for use in children and adolescents with a psychotic illness, and to determine of Ziprasidone treatment leads to weight changes in children.

NCT ID: NCT00035802 Completed - Bipolar Disorder Clinical Trials

A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder

Start date: January 2002
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the safety and efficacy of topiramate in adolescents with manic or mixed episodes of Bipolar I Disorder.